Spin-off of the Science Business and Autonomous Growth
First written in FY2022-Q3. 2 of 5 entries say "Achieved", first in FY2022. Latest entry: FY2024-Q1.
No other company in this theme has enough history to compare yet.
- FY2024-Q1AchievedAnnual report
「In accordance with the above share transfer agreement, we completed the transfer on 3 April 2023 of all shares of Evident, our consolidated subsidiary that had assumed our Scientific Solutions Business through an absorption-type company split.」
Following the spin-off of the Scientific Solutions Business, we completed the transfer of all shares to Bain Capital's side on 3 April 2023, reaching closing. - FY2023-Q3SoftenedAnnual report
「Completion of this share transfer was subject to obtaining approvals from the relevant authorities under competition laws and other applicable laws in Japan and overseas. Because fulfillment of these conditions was taking time in certain countries, following discussions with Bain Capital, we changed the scheduled closing date for this share transfer from “4 January 2023 (scheduled)” to “February 2023 (scheduled).” Subsequently, between the end of the consolidated accounting period for the third quarter and the date of submission of this quarterly securities report, we changed the scheduled closing date for this share transfer from “February 2023 (scheduled)” to “March 2023 (scheduled).”」
For the transfer of the Scientific Solutions Business to Bain Capital's side, obtaining approvals from the relevant authorities took time, and the scheduled closing date was postponed from January 2023 to February and then to March. - FY2023-Q2AdvancedAnnual report
「On 29 August 2022, we entered into a share transfer agreement with BCJ-66, a special-purpose company whose shares are indirectly held by an investment fund advised by Bain Capital, to transfer all shares of Evident, a specified subsidiary, for the purpose of transferring our Group's Scientific Solutions Business.」
Following the spin-off of the Scientific Solutions Business, we entered into an agreement with Bain Capital's side to transfer all shares of Evident. The transfer price was ¥427.674 billion, and the scheduled closing date was 4 January 2023. - FY2022AchievedAnnual report
「We completed the company split transferring our Scientific Solutions Business to Evident, a newly established wholly owned subsidiary, effective 1 April 2022.」
The spin-off of the Scientific Solutions Business was completed on 1 April 2022. We moved to the stage of establishing management structures suited to the characteristics of the Scientific Solutions Business and the Medical Business. - FY2022-Q3First statedAnnual report
「At a meeting of the Board of Directors held on 17 December 2021, we resolved to transfer our Scientific Solutions Business through an absorption-type company split to Evident, a newly established wholly owned subsidiary, with 1 April 2022 as the scheduled effective date.」
We decided to transfer the Scientific Solutions Business through an absorption-type company split scheduled for 1 April 2022. The purpose was to achieve sustainable growth and improve profitability in the Scientific Solutions Business and establish management structures suited to the characteristics of the Medical Business and the Scientific Solutions Business.